“Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido Thiazolyl Resorcinol) in Melasma”. SKIN The Journal of Cutaneous Medicine 9, no. 2 (March 17, 2025): s544. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/3315.